This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Cancer Prevention Pharmaceuticals, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Michelle Boytim and a Patent for Familial Adenomatous Polyposis Treatment.
Introduction
Michelle Boytim is an inventor associated with Tucson, Arizona. Her patent work addresses potential approaches to treating familial adenomatous polyposis (FAP), an inherited condition that can lead to colorectal neoplasia and cancer.
Latest Patents
Boytim is associated with 1 patent, titled “Methods for Treating Familial Adenomatous Polyposis.” The patent describes methods intended to prevent or delay the need for surgical intervention, as well as the formation of neoplasia or cancer, in patients with FAP and an at least partially intact lower gastrointestinal tract. The proposed therapy combines eflornithine and sulindac.
Career Highlights
Boytim is associated with Cancer Prevention Pharmaceuticals, Inc. and Creative Business Planning Alliance LLC. Her patent reflects work focused on pharmaceutical approaches to cancer prevention and treatment.
Collaborations
The patent lists Eugene W. Gerner and Alfred S. Cohen among Boytim’s collaborators. Their shared work concerns methods for treating FAP using a combination of eflornithine and sulindac.
Conclusion
Michelle Boytim’s patent highlights an approach aimed at delaying surgery and reducing the risk of neoplasia or cancer for people with FAP.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile